Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 2, 2009, Pages 181-189

  Aasen, Gunnar ^a   Fagertun, Hans ^b   Tonstad, Serena ^c   Halse, Johan ^a  

^a Spesialistsenteret Pilestredet Park   (Norway)

^b Capturo AS   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

DXA; Dyslipidaemia; Insulin resistance; Leg fat mass; Trunk fat mass

Indexed keywords

CHOLESTEROL; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEG; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC CLEARANCE RATE; MULTIPLE REGRESSION; OBESITY; PANCREAS ISLET BETA CELL; POSTMENOPAUSE; PRIORITY JOURNAL; ADIPOSE TISSUE; GLUCOSE TOLERANCE TEST; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PREMENOPAUSE; RADIOGRAPHY; REGRESSION ANALYSIS;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; AGED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LEG; MALE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; REGRESSION ANALYSIS;

EID: 65649096606     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802464641     Document Type: Article

References (39)

1. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:8-98.
2. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-43.
3. Carey DG, Jenkins AB, Campbell LV, Freund J, Chrisholm DJ. Abdominal fat and insulin resistance in normal and overweight women. Diabetes 1996;45:633-8.
4. Despres J-P. Abdominal obesity as important component of insulin resistance syndrome. Nutrition 1993;9:452-9.
5. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 2004;27:372-7.
6. Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C. Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001;9:644-9.
7. Heitmann BL, Frederiksen P, Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004;12:482-7.
8. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 2003;77:1192-7.
9. Snijder MB, Dekker JM, Visser M, Yudkin JS, Coen DA, Stehouwer LM, et al. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res 2003;11:104-11.
10. Seidell JC, Pérusse L, Deprés J-P, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk: the Quebec family study. Am J Clin Nutr 2001;74:315-21.
11. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab study. Int J Obes Relat Metab Disord 2004;28:402-9.
12. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, Treuth MS. Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr 1997;65:855-60.
13. Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003;107:1626-31.
14. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contribution of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002;282:E1023-8.
15. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 2005;90:4573-8.
16. Sakai Y, Ito H, Egami Y, Ohoto N, Hijii C, Yanagawa M, et al. Favourable association of leg fat with cardiovascular risk factors. J Inter Med 2005;257:194-200.
17. Khee Gan Seng, Kriketos AD, Poynten AM, Furler SM, Thompson CH, Kraegen EW, et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 2003;11:1295-305.
18. Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, et al. Dual energy x-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999;22:1310-17.
19. Pouliot M-C, Despres J-P, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ, et al. Visceral obesity in men: association with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826-34.
20. Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-8.
21. Tatsukawa M, Kurokawa M, Tamari Y, Yoshimatsu H, Sakata T. Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenesity in Japanese. Proc Soc Exp Bio Med 2000;223:156-62.
22. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005;165:777-83.
23. Aasen G, Fagertun H, Halse J. Body composition analysis by dual X- ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments. Scand J Clin Lab Invest 2006;66:659-66.
24. Aasen G, Fagertun H, Halse J. Regional fat mass by DXA: High leg fat mass attenuates relative risk for insulin resistance and dyslipidemia in obese but not in overweight postmenopausal women. Scand J Clin Lab Invest 2008;68:204-11.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
26. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianai F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
27. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Jarvinen HY, Van Haften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
28. Friedewald WT, Levy RI, Fredrichson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29. Tchernof A, Poehlman ET, Despres JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes & Metabolism (Paris) 2000;26:12-20.
30. Abate N, Haffner SM, Abhimanyu G, Peshock RM, Scott MG. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002;87:4522-7.
31. Shand BI, Scott RS, Elder PA, George PM. Plasme adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-53.
32. Hanley AJG, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in non-diabetic Hispanic and African Americans. J Clin Endocrinol Metab 2007. doi: 10.1210/ jc.2006-614.
33. Buemann B, Sørensen TIA, Pedersen O, Black E, Holst C, Toubro S, et al. Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin. Int J Obes 2005;29:624-31.
34. Buemann B, Astrup A, Pedersen O, Black E, Holst C, Toubro S, et al. Possible role of adiponectin and insulin sensitivity in mediating the favourable effects of lower body fat mass on blood lipids. J Clin Endocrinol Metab 2006;91:1698-704.
35. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003;11:368-72.
36. Marette A, Mauriege P, Marcotte B, Atgie C, Bouchard C, Theriault C, et al. Regional variations in adipose tissue insulin action and GLUT4 transporter expression in severely obese premenopausal women. Diabetologia 1997;40:590-8.
37. Bos G, Snijder MB, Nijpels G, Dekker JM, Stehouwer CDA, Bouter LM, et al. Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn Study. Obes Res 2005;13:1817-23.
38. Hanley AJG, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance of cardiovascular disease. The San Antonio Heart Study. Diabetes Care 2002;25:1177-84.
39. Huptas S, Geiss HC, Otto C, Parhofer KG. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome. Am J Cardiol 2006;1:66-9.